bioXXmed AG reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 0.012233 million compared to EUR 0.044626 million a year ago. Net loss was EUR 0.829837 million compared to EUR 4.06 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.406 EUR | 0.00% | -13.25% | -8.97% |
2023 | BioXXmed AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | BioXXmed AG Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
1st Jan change | Capi. | |
---|---|---|
-8.97% | 2.25M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- T5O Stock
- News bioXXmed AG
- BioXXmed AG Reports Earnings Results for the Full Year Ended December 31, 2022